Investegate |Galapagos NV Announcements | Galapagos NV: Galapagos announces full year 2022 results and outlook for 2023

Investegate announcements from Galapagos NV, Galapagos announces full year 2022 results and outlook for 2023

Related Keywords

Japan ,Mechelen ,Region Flamande ,Belgium ,Usiki ,Perifereia Thessalias ,Greece ,United Kingdom ,Czech Republic ,Portugal ,Russia ,Ukraine ,Great Britain ,Paul Stoffel ,Paul Stoffels ,Van Gijsel ,Bart Filius ,Sandra Cauwenberghs ,Marieke Vermeersch ,Annelies Missotten ,Walid Abi Saab ,Cellpointand Aboundbio ,Elisa Chenailler ,Valeria Cnossen ,Pharmacovigilance Risk Assessment Committee ,European Commission Under Article ,Linkedin ,Twitter ,Ministry Of Health ,European Hematology Association ,European Union ,Committee For Medicinal Products Human Use ,Gilead Sciences ,European Commission ,Regulatory Agency ,Exchange Commission ,Society Of Hematology ,Committee For Medicinal Products Human ,European Society For Blood ,European Medicines Agency ,Chief Executive Officer ,Medicinal Products ,Human Use ,Marketing Authorization Application ,Central Europe ,Onno Van De Stolpe ,Executive Committee ,Chief Medical Officer ,Chief Business Officer ,General Counsel ,Chief Human Resources Officer ,Objective Response Rate ,World Evidence Phase ,Annual Report ,Multiple Myeloma ,Marrow Transplantation ,Investegate Announcements ,Investegate Company Announcements ,Galapagos Nv ,Lobenewswire ,Lobenewswire And Globenewswire ,Nw ,